Identification of immune-related target and prognostic biomarkers in PBMC of hepatocellular carcinoma

BACKGROUND:  Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide, and is characterized by insidious onset, rapid progression, and poor prognosis. Immunotherapy is a first-line treatment for advanced HCC. The identification of immune-related prognostic markers...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Rui, Zhang, Wei, Han, Zhiyi, Ma, Mengqing, Huang, Qi, Lv, Minling, Ma, Wenfeng, Sun, Xinfeng, Feng, Wenxing, Li, Jing, Zhong, Xin, Sun, Jialing, Yao, Wei, Zhou, Xiaozhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337054/
https://www.ncbi.nlm.nih.gov/pubmed/37438735
http://dx.doi.org/10.1186/s12876-023-02843-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337054/
https://www.ncbi.nlm.nih.gov/pubmed/37438735
http://dx.doi.org/10.1186/s12876-023-02843-y

Ejemplares similares